Odyssey Therapeutics, Inc. (ODTX) Stock Statistics & Valuation Metrics

Odyssey Therapeutics, Inc. has a market cap or net worth of $806.93M. The enterprise value is $0.00.

Odyssey Therapeutics, Inc. has 48,031,320 shares outstanding. The number of shares has decreased by -2.65% in one year.

Odyssey Therapeutics, Inc.’s return on equity (ROE) is 0.30 and return on invested capital (ROIC) is -64.44%.

The current PE Ratio of Odyssey Therapeutics, Inc. is ―. Odyssey Therapeutics, Inc.’s PEG ratio is 0.00.

In the last 12 months, Odyssey Therapeutics, Inc. had revenue of 2.98M and earned -148.65M in profits. Earnings per share was -5.39.

In the last 12 months, operating cash flow was -41.03M and capital expenditures -148.00K, giving a free cash flow of -41.18M billion.

Odyssey Therapeutics, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Odyssey Therapeutics, Inc. upcoming earnings date is Jun 17, 2026, After Close (Confirmed).

Odyssey Therapeutics, Inc. as a current ratio of 7.20, with Debt / Equity ratio of -5.55%

In the past 12 months, Odyssey Therapeutics, Inc. has paid -927.00K in taxes.

Odyssey Therapeutics, Inc. EV to EBITDA ratio is -3.03, with an EV/FCF ratio of -3.35.

Odyssey Therapeutics, Inc. has $175.75M in cash and marketable securities with $26.13M in debt, giving a net cash position of $149.62M billion.

Gross margin is 100.00%, with operating margin of -5415.19%, and net profit margin of -4994.86%.

The average price target for Odyssey Therapeutics, Inc. is $32.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy